相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mismatch repair protein loss in breast cancer: clinicopathological associations in a large British Columbia cohort
Angela S. Cheng et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice
Paula Gonzalez-Ericsson et al.
JOURNAL OF PATHOLOGY (2020)
PD-L1 and CD8 are associated with deficient mismatch repair status in triple-negative and HER2-positive breast cancers
Yanjun Hou et al.
HUMAN PATHOLOGY (2019)
Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers
Sherene Loi et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
The Relationship Between Mismatch Repair Deficiency and PD-L1 Expression in Breast Carcinoma
Anne M. Mills et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2018)
PD-L1 and Emerging Biomarkers in Immune Checkpoint Blockade Therapy
Tricia R. Cottrell et al.
CANCER JOURNAL (2018)
PD-L1 expression and CD8-positive T cells are associated with favorable survival in HER2-positive invasive breast cancer
Yanjun Hou et al.
BREAST JOURNAL (2018)
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
P. Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Control of PD-L1 Expression by Oncogenic Activation of the AKT-mTOR Pathway in Non-Small Cell Lung Cancer
Kristin J. Lastwika et al.
CANCER RESEARCH (2016)
Microsatellite Instability as a Biomarker for PD-1 Blockade
Jonathan C. Dudley et al.
CLINICAL CANCER RESEARCH (2016)
Programmed death ligand 1 expression in triple-negative breast cancer is associated with tumour-infiltrating lymphocytes and improved outcome
Rhiannon K. Beckers et al.
HISTOPATHOLOGY (2016)
Prognostic significance of PD-L1 and PD-L2 in breast cancer
Mauricio Z. Baptista et al.
HUMAN PATHOLOGY (2016)
Strategies for developing Ki67 as a useful biomarker in breast cancer
Carsten Denkert et al.
BREAST (2015)
Differential Expression of Immune-Regulatory Genes Associated with PD-L1 Display in Melanoma: Implications for PD-1 Pathway Blockade
Janis M. Taube et al.
CLINICAL CANCER RESEARCH (2015)
Prognostic and predictive value of PDL1 expression in breast cancer
Renaud Sabatier et al.
ONCOTARGET (2015)
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
R. Salgado et al.
ANNALS OF ONCOLOGY (2015)
Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti-PD-1 Therapy
Janis M. Taube et al.
CLINICAL CANCER RESEARCH (2014)
DNA Mismatch Repair Deficiency in Breast Carcinoma A Pilot Study of Triple-negative and Non-Triple-negative Tumors
Yong H. Wen et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Relevance, Pathogenesis, and Testing Algorithm for Mismatch Repair-Defective Colorectal Carcinomas A Report of the Association for Molecular Pathology
William K. Funkhouser et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2012)
分享论文
